Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of COVID-19-related Medication Assisted Treatment Policy Changes on Care and Outcomes for Patients With Opioid Use Disorder

NCT05028998 is registered in ClinicalTrials.gov with Boston VA Research Institute, Inc. as lead sponsor.

NCT NCT05028998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of COVID-19-related Medication Assisted Treatment Policy Changes on Care and Outcomes for Patients With Opioid Use Disorder
Lead sponsor
Boston VA Research Institute, Inc.
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2021
Completion date
August 31, 2023
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, opioid-use disorder